Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Muna Therapeutics ApS
APS
Active
Advertising protection
CVR 41142871
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2020 · 6 years old
18 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Muna Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Related companies
Company hierarchy
Novo Nordisk Fonden
100%
Novo Holdings A/S
15%
Sanofi Foreign Participations B.V.
5%
Joachim Vilstrup Holding ApS
5%
Peder Søndergaard Madsen Consulting ApS
5%
WoB Holding ApS
10%
Camilla Gustafsen Consulting ApS
5%
Simon Glerup Consulting ApS
5%
S. Skeldal Holding ApS
5%
Muna Therapeutics ApS
(this company)
Board network connections
Board members of Muna Therapeutics ApS also hold positions in
20
other companies.
Person
Role here
Other companies
Henrijette Elsebeth Richter
Board of Directors
6 companies
Many roles
Anders Mørkeberg Hinsby
Chief Executive Officer
4 companies
Simon Glerup Pedersen
Board of Directors
3 companies
Camilla Petrycer Hansen
Board of Directors
3 companies
Joachim Pold Vilstrup
Chief Executive Officer
1 company
Peder Søndergaard Madsen
Chairman
1 company
Morten Døssing
Chairman
1 company
Chiara Rossana Maria Liberati
Board of Directors
1 company
More on Muna Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
People & ownership →
Management, board and shareholder breakdown
Novo Nordisk Fonden
Muna Therapeutics ApS